Evidence map›Paper›PMID 38547501›Full record

ArticleEuropean journal of public health2024

Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium.

Tugce Schmitt, Marie Delnord, Emilie Cauët, Els Van Valckenborgh, Marc Van den Bulcke

Open access · goldAbstract read
In one paragraph

Article in European journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tugce SchmittCancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.ORCID 0000-0001-6893-6428
Marie DelnordCancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.ORCID 0000-0002-3168-0219
Emilie CauëtCancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Els Van ValckenborghCancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Marc Van den BulckeCancer Centre, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Sciensano (Belgium) · BE

Funding

European Union's Horizon 2020 101018317
6 · The paper itself

Abstract

backgroundPrecision medicine represents a paradigm shift in health systems, moving from a one-size-fits-all approach to a more individualized form of care, spanning multiple scientific disciplines including drug discovery, genomics, and health communication. This study aims to explore the contextual factors influencing the equitable implementation of precision medicine in Belgium for incorporating precision medicine into routine cancer care within the Belgian health system.

methodsAs part of a foresight study, our approach evaluates critical factors affecting the implementation of precision oncology. The study scrutinizes contextual, i.e. demographic, economic, societal, technological, environmental, and political/policy-related (DESTEP) factors, identified through a comprehensive literature review and validated by a multidisciplinary group at the Belgian Cancer Center, Sciensano. An expert survey further assesses the importance and likelihood of these factors, illuminating potential barriers and facilitators to implementation.

resultsBased on the expert survey, five key elements (rising cancer rates, dedicated healthcare reimbursement budgets, increasing healthcare expenditures, advanced information technology solutions for data transfer, and demand for high-quality data) are expected to influence the equitable implementation of precision medicine in routine cancer care in Belgium in the future.

conclusionsThis work contributes to the knowledge base on precision medicine in Belgium and public health foresight, exploring the implementation challenges and suggesting solutions with an emphasis on the importance of comparative analyses of health systems, evaluation of health technology assessment methods, and the exploration of ethical issues in data privacy and equity.

Indexed as

NeoplasmsPrecision MedicineBelgiumHumans

Identifiers

PMID38547501
PMCPMC11293814
OpenAlexW4393251246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.